Physician profile
Craig L Zaretsky
NPI 1841304623
$23,134.25
in general payments reported to CMS, 2019-2025
14 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,799 · 2020: $233 · 2021: $302 · 2022: $224 · 2023: $1,342 · 2024: $3,919 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,500 · Food and Beverage: $4,107 · Education: $3,774 · Travel and Lodging: $3,146 · Gift: $49.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,500.00 |
| Food and Beverage | $4,107.42 |
| Education | $3,774.12 |
| Travel and Lodging | $3,145.62 |
| Gift | $49.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,976.63 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $380.36 | 2021-2025 | Progrip, Dextile, Parietex |
| Smith+Nephew, INC. | $220.94 | 2019-2024 | Pico 7 |
| Davol INC. | $172.61 | 2019-2025 | Phasix Mesh |
| Baxter Healthcare | $103.41 | 2019-2022 | |
| Integra Lifesciences Corporation | $86.07 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $50.02 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $36.83 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $22.50 | 2022 | |
| Covidien LP | $19.55 | 2019 | |
| Conmed Corporation | $17.71 | 2024 | Airseal |
| Vertex Pharmaceuticals Incorporated | $17.04 | 2025 | |
| Olympus America INC. | $15.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.66 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Zaretsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.